UDK: 616.127-005.8:616.12-008.46:616.379-008.64:616.89:615.214.32
M. E. Statsenko, N. N. Shilina
Кафедра внутренних болезней педиатрического и стоматологического факультетов ВолГМУ
The study of sertralin therapy influence on affective disorders expression in chronic heart failure and diabetes type 2 patients during early post-infarction period was carried out. Statistically significant elimination of depression and anxiety, decreased psychological stress level, reduced autonomous dysfunction signs, improved spleep at the background of sertralin application were discovered in treated patients, and as a result improved quality of life was demonstrated in chronic heart failure and diabetes type 2 patients suffering affective disorders.
sertralin, affective disorders, chronic heart failure, diabetes type 2, early post-infarction period.
Стаценко Михаил Евгеньевич – д.м.н., профессор, проректор по НИР, зав. кафедрой внутренних болезней педиатрического и стоматологического факультетов Волгоградского государственного медицинского университета, statsenko@vistcom.ru